Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' HIRSCH EC' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 112 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Marin, C; Jimenez, A; Bonastre, M; Vila, M; Agid, Y; Hirsch, EC; Tolosa, E
      LY293558, an AMPA glutamate receptor antagonist, prevents and reverses levodopa-induced motor alterations in parkinsonian rats

      SYNAPSE
    2. Turmel, H; Hartmann, A; Parain, K; Douhou, A; Srinivasan, A; Agid, Y; Hirsch, EC
      Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice

      MOVEMENT DISORDERS
    3. Hartmann, A; Troadec, JD; Hunot, S; Kikly, K; Faucheux, BA; Mouatt-Prigent, A; Ruberg, M; Agid, Y; Hirsch, EC
      Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal necrosis

      JOURNAL OF NEUROSCIENCE
    4. Hartmann, A; Michel, PP; Troadec, JD; Mouatt-Prigent, A; Faucheux, BA; Ruberg, M; Agid, Y; Hirsch, EC
      Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neuronsin Parkinson's disease?

      JOURNAL OF NEUROCHEMISTRY
    5. Zarate-Lagunes, M; Gu, WJ; Blanchard, V; Francois, C; Muriel, MP; Mouatt-Prigent, A; Bonici, B; Parent, A; Hartmann, A; Yelnik, J; Boehme, GA; Pradier, L; Moussaoui, S; Faucheux, B; Raisman-Vozari, R; Agid, Y; Brice, A; Hirsch, EC
      Parkin immunoreactivity in the brain of human and non-human primates: An immunohistochemical analysis in normal conditions and in Parkinsonian syndromes

      JOURNAL OF COMPARATIVE NEUROLOGY
    6. Perier, C; Agid, Y; Hirsch, EC; Feger, J
      Ipsilateral and contralateral subthalamic activity after unilateral dopaminergic lesion

      NEUROREPORT
    7. Vila, M; Perier, C; Feger, J; Yelnik, J; Faucheux, B; Ruberg, M; Raisman-Vozari, R; Agid, Y; Hirsch, EC
      Evolution of changes in neuronal activity in the subthalamic nucleus of rats with unilateral lesion of the substantia nigra assessed by metabolic andelectrophysiological measurements

      EUROPEAN JOURNAL OF NEUROSCIENCE
    8. Hirsch, EC
      Nigrostriatal system plasticity in Parkinson's disease: Effect of dopaminergic denervation and treatment

      ANNALS OF NEUROLOGY
    9. Muriel, MP; Bernard, V; Levey, AI; Laribi, O; Abrous, DN; Agid, Y; Bloch, B; Hirsch, EC
      Levodopa induces a cytoplasmic localization of D1 dopamine receptors in striatal neurons in Parkinson's disease - Reply

      ANNALS OF NEUROLOGY
    10. Hirsch, EC
      Glial cells and Parkinson's disease

      JOURNAL OF NEUROLOGY
    11. Orieux, G; Francois, C; Feger, J; Yelnik, J; Vila, M; Ruberg, M; Agid, Y; Hirsch, EC
      Metabolic activity of excitatory parafascicular and pedunculopontine inputs to the subthalamic nucleus in a rat model of Parkinson's disease

      NEUROSCIENCE
    12. Ransmayr, G; Faucheux, B; Nowakowski, C; Kubis, N; Federspiel, S; Kaufmann, W; Henin, D; Hauw, JJ; Agid, Y; Hirsch, EC
      Age-related changes of neuronal counts in the human pedunculopontine nucleus

      NEUROSCIENCE LETTERS
    13. Hirsch, EC; Perier, C; Orieux, G; Francois, C; Feger, J; Yelnik, J; Vila, M; Levy, R; Tolosa, ES; Marin, C; Herrero, MT; Obeso, JA; Agid, Y
      Metabolic effects of nigrostriatal denervation in basal ganglia

      TRENDS IN NEUROSCIENCES
    14. Damier, P; Tremblay, L; Feger, J; Hirsch, EC
      Development of dyskinesias induced by treatment for Parkinson's disease: potential role of first exposure to L-DOPA (priming).

      REVUE NEUROLOGIQUE
    15. Hartmann, A; Hunot, S; Michel, PP; Muriel, MP; Vyas, S; Faucheux, BA; Mouatt-Prigent, A; Turmel, H; Srinivasan, A; Ruberg, M; Evan, GI; Agid, Y; Hirsch, EC
      Caspase-3: A vulnerability factor and final effector in apoptotic death ofdopaminergic neurons in Parkinson's disease

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    16. Gu, WJ; Abbas, N; Lagunes, MZ; Parent, A; Pradier, L; Bohme, GA; Agid, Y; Hirsch, EC; Raisman-Vozari, R; Brice, A
      Cloning of rat parkin cDNA and distribution of parkin in rat brain

      JOURNAL OF NEUROCHEMISTRY
    17. Muriel, MP; Lambeng, N; Darios, F; Michel, PP; Hirsch, EC; Agid, Y; Ruberg, M
      Mitochondrial free calcium levels (Rhod-2 fluorescence) and ultrastructural alterations in neuronally differentiated PC12 cells during ceramide-dependent cell death

      JOURNAL OF COMPARATIVE NEUROLOGY
    18. Francois, C; Savy, C; Jan, C; Tande, D; Hirsch, EC; Yelnik, J
      Dopaminergic innervation of the subthalamic nucleus in the normal state, in MPTP-treated monkeys, and in Parkinson's disease patients

      JOURNAL OF COMPARATIVE NEUROLOGY
    19. Mouatt-Prigent, A; Karlsson, JO; Yelnik, J; Agid, Y; Hirsch, EC
      Calpastatin immunoreactivity in the monkey and human brain of control subjects and patients with Parkinson's disease

      JOURNAL OF COMPARATIVE NEUROLOGY
    20. Dubus, P; Faucheux, B; Boissiere, F; Groppi, A; Vital, C; Vital, A; Agid, Y; Hirsch, EC; Merlio, JP
      Expression of Trk isoforms in brain regions and in the striatum of patients with Alzheimer's disease

      EXPERIMENTAL NEUROLOGY
    21. Perier, C; Vila, M; Feger, J; Agid, Y; Hirsch, EC
      Functional activity of zona incerta neuron is altered after nigrostriatal denervation in hemiparkinsonian rats

      EXPERIMENTAL NEUROLOGY
    22. Kubis, N; Faucheux, BA; Ransmayr, G; Damier, P; Duyckaerts, C; Henin, D; Forette, B; Le Charpentier, Y; Hauw, JJ; Agid, Y; Hirsch, EC
      Preservation of midbrain catecholaminergic neurons in very old human subjects

      BRAIN
    23. Hirsch, EC; Hunot, S
      Nitric oxide, glial cells and neuronal degeneration in parkinsonism

      TRENDS IN PHARMACOLOGICAL SCIENCES
    24. Hirsch, EC; Hunot, S; Faucheux, B; Agid, Y; Mizuno, Y; Mochizuki, H; Tatton, WG; Tatton, N; Olanow, WC
      Dopaminergic neurons degenerate by apoptosis in Parkinson's disease

      MOVEMENT DISORDERS
    25. Muriel, MP; Bernard, V; Levey, AI; Laribi, O; Abrous, DN; Agid, Y; Bloch, B; Hirsch, EC
      Levodopa induces a cytoplasmic localization of D1 dopamine receptors in striatal neurons in Parkinson's disease

      ANNALS OF NEUROLOGY
    26. Hirsch, EC
      Mechanism and consequences of nerve cell death in Parkinson's disease

      JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT
    27. Hunot, S; Dugas, N; Faucheux, B; Hartmann, A; Tardieu, M; Debre, P; Agid, Y; Dugas, B; Hirsch, EC
      Fc epsilon RII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells

      JOURNAL OF NEUROSCIENCE
    28. Faucheux, BA; Bonnet, AM; Agid, Y; Hirsch, EC
      Blood vessels change in the mesencephalon of patients with Parkinson's disease

      LANCET
    29. Vila, M; Marin, C; Ruberg, M; Jimenez, A; Raisman-Vozari, R; Agid, Y; Tolosa, E; Hirsch, EC
      Systemic administration of NMDA and AMPA receptor antagonists reverses theneurochemical changes induced by nigrostriatal denervation in basal ganglia

      JOURNAL OF NEUROCHEMISTRY
    30. Francois, C; Yelnik, J; Tande, D; Agid, Y; Hirsch, EC
      Dopaminergic cell group A8 in the monkey: Anatomical organization and projections to the striatum

      JOURNAL OF COMPARATIVE NEUROLOGY
    31. Damier, P; Hirsch, EC; Agid, Y; Graybiel, AM
      The substantia nigra of the human brain - I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D-28K immunohistochemistry

      BRAIN
    32. Damier, P; Hirsch, EC; Agid, Y; Graybiel, AM
      The substantia nigra of the human brain - II. Patterns of loss of dopamine-containing neurons in Parkinson's disease

      BRAIN
    33. HOLMBERG M; DUYCKAERTS C; DURR A; CANCEL G; GOURFINKELAN I; DAMIER P; FAUCHEUX B; TROTTIER Y; HIRSCH EC; AGID Y; BRICE A
      SPINOCEREBELLAR ATAXIA TYPE-7 (SCA7) - A NEURODEGENERATIVE DISORDER WITH NEURONAL INTRANUCLEAR INCLUSIONS

      Human molecular genetics
    34. GOURFINKELAN I; CANCEL G; DUYCKAERTS C; FAUCHEUX B; HAUW JJ; TROTTIER Y; BRICE A; AGID Y; HIRSCH EC
      NEURONAL DISTRIBUTION OF INTRANUCLEAR INCLUSIONS IN HUNTINGTONS-DISEASE WITH ADULT-ONSET

      NeuroReport
    35. HUNOT S; DUGAS N; DUGAS B; MICHEL PP; FAUCHEUX B; AGID Y; HIRSCH EC
      INFLAMMATORY MEDIATORS ARE EXPRESSED IN THE SUBSTANTIA-NIGRA OF PATIENTS WITH PARKINSONS-DISEASE

      European journal of neuroscience
    36. HIRSCH EC; FAUCHEUX BA
      IRON-METABOLISM AND PARKINSONS-DISEASE

      Movement disorders
    37. HIRSCH EC; HUNOT S; DAMIER P; FAUCHEUX B
      GLIAL-CELLS AND INFLAMMATION IN PARKINSONS-DISEASE - A ROLE IN NEURODEGENERATION

      Annals of neurology
    38. HARTMANN A; HUNOT S; HIRSCH EC; HIRSCH C
      CD95 (APO-1 FAS) AND PARKINSONS-DISEASE

      Annals of neurology
    39. BENISTY S; BOISSIERE F; FAUCHEUX B; AGID Y; HIRSCH EC
      TRKB MESSENGER-RNA EXPRESSION IN NORMAL HUMAN BRAIN AND IN THE SUBSTANTIA-NIGRA OF PARKINSONIAN-PATIENTS - AN IN-SITU HYBRIDIZATION STUDY

      Neuroscience
    40. BOISSIERE F; FAUCHEUX B; DUYCKAERTS C; HAUW JJ; AGID Y; HIRSCH EC
      STRIATAL EXPRESSION OF GLUTAMIC-ACID DECARBOXYLASE GENE IN ALZHEIMERS-DISEASE

      Journal of neurochemistry
    41. Villares, J; Faucheux, B; Herrero, MT; Obeso, JA; Duyckaerts, C; Hauw, JJ; Agid, Y; Hirsch, EC
      [I-125]EGF binding in basal ganglia of patients with Parkinson's disease and progressive supranuclear palsy and in MPTP-treated monkeys

      EXPERIMENTAL NEUROLOGY
    42. BOISSIERE F; HUNOT S; FAUCHEUX B; DUYCKAERTS C; HAUW JJ; AGID Y; HIRSCH EC
      NUCLEAR TRANSLOCATION OF NF-KAPPA-B IN CHOLINERGIC NEURONS OF PATIENTS WITH ALZHEIMERS-DISEASE

      NeuroReport
    43. GOURFINKELAN I; CANCEL G; TROTTIER Y; DEVYS D; TORA L; LUTZ Y; IMBERT G; SAUDOU F; STEVANIN G; AGID Y; BRICE A; MANDEL JL; HIRSCH EC
      DIFFERENTIAL DISTRIBUTION OF THE NORMAL AND MUTATED FORMS OF HUNTINGTIN IN THE HUMAN BRAIN

      Annals of neurology
    44. LEVY R; HAZRATI LN; HERRERO MT; VILA M; HASSANI OK; MOUROUX M; RUBERG M; ASENSI H; AGID Y; FEGER J; OBESO JA; PARENT A; HIRSCH EC
      REEVALUATION OF THE FUNCTIONAL-ANATOMY OF THE BASAL GANGLIA IN NORMALAND PARKINSONIAN STATES

      Neuroscience
    45. BOISSIERE F; FAUCHEUX B; AGID Y; HIRSCH EC
      CHOLINE-ACETYLTRANSFERASE MESSENGER-RNA EXPRESSION IN THE STRIATAL NEURONS OF PATIENTS WITH ALZHEIMERS-DISEASE

      Neuroscience letters
    46. BOISSIERE F; FAUCHEUX B; AGID Y; HIRSCH EC
      EXPRESSION OF CATALYTIC TRKB GENE IN THE STRIATUM AND THE BASAL FOREBRAIN OF PATIENTS WITH ALZHEIMERS-DISEASE - AN IN-SITU HYBRIDIZATION STUDY

      Neuroscience letters
    47. HIRSCH EC; FAUCHEUX B; DAMIER P; MOUATTPRIGENT A; AGID Y
      NEURONAL VULNERABILITY IN PARKINSONS-DISEASE

      Journal of neural transmission. Supplementum
    48. VILA M; LEVY R; HERRERO MT; RUBERG M; FAUCHEUX B; OBESO JA; AGID Y; HIRSCH EC
      CONSEQUENCES OF NIGROSTRIATAL DENERVATION ON THE FUNCTIONING OF THE BASAL GANGLIA IN HUMAN AND NONHUMAN-PRIMATES - AN IN-SITU HYBRIDIZATIONSTUDY OF CYTOCHROME-OXIDASE SUBUNIT-I MESSENGER-RNA

      The Journal of neuroscience
    49. ANGLADE P; VYAS S; HIRSCH EC; AGID Y
      APOPTOSIS IN DOPAMINERGIC-NEURONS OF THE HUMAN SUBSTANTIA-NIGRA DURING NORMAL AGING

      Histology and histopathology
    50. ANGLADE P; VYAS S; JAVOYAGID F; HERRERO MT; MICHEL PP; MARQUEZ J; MOUATTPRIGENT A; RUBERG M; HIRSCH EC; AGID Y
      APOPTOSIS AND AUTOPHAGY IN NIGRAL NEURONS OF PATIENTS WITH PARKINSONS-DISEASE

      Histology and histopathology
    51. DAMIER PG; GRAYBIEL AM; AGID YA; HIRSCH EC
      DOES ASTROGLIAL ENVIRONMENT PLAY A ROLE IN SELECTIVITY OF DOPAMINERGIC LESION IN PARKINSONS-DISEASE

      Neurology
    52. HUNOT S; BRUGG B; RICARD D; MICHEL PP; MURIEL MP; RUBERG M; FAUCHEUX BA; AGID Y; HIRSCH EC
      NUCLEAR TRANSLOCATION OF NF-KAPPA-B IS INCREASED IN DOPAMINERGIC-NEURONS OF PATIENTS WITH PARKINSON-DISEASE

      Proceedings of the National Academy of Sciences of the United Statesof America
    53. BOISSIERE F; FAUCHEUX B; RUBERG M; AGID Y; HIRSCH EC
      DECREASED TRKA GENE-EXPRESSION IN CHOLINERGIC NEURONS OF THE STRIATUMAND BASAL FOREBRAIN OF PATIENTS WITH ALZHEIMERS-DISEASE

      Experimental neurology
    54. FAUCHEUX BA; HAUW JJ; AGID Y; HIRSCH EC
      THE DENSITY OF [I-125] TRANSFERRIN-BINDING SITES ON PERIKARYA OF MELANIZED NEURONS OF THE SUBSTANTIA-NIGRA IS DECREASED IN PARKINSONS-DISEASE

      Brain research
    55. BOISSIERE F; HUNOT S; FAUCHEUX B; HERSH LB; AGID Y; HIRSCH EC
      TRK NEUROTROPHIN RECEPTORS IN CHOLINERGIC NEURONS OF PATIENTS WITH ALZHEIMERS-DISEASE

      Dementia and geriatric cognitive disorders
    56. ANGLADE P; MOUATTPRIGENT A; AGID Y; HIRSCH EC
      SYNAPTIC PLASTICITY IN THE CAUDATE-NUCLEUS OF PATIENTS WITH PARKINSONS-DISEASE

      Neurodegeneration
    57. BOISSIERE F; LEHERICY S; STRADA O; AGID Y; HIRSCH EC
      NEUROTROPHIN RECEPTORS AND SELECTIVE LOSS OF CHOLINERGIC NEURONS IN ALZHEIMER-DISEASE

      Molecular and chemical neuropathology
    58. BOISSIERE F; PRADIER L; DELAERE P; FAUCHEUX B; REVAH F; BRICE A; AGID Y; HIRSCH EC
      REGIONAL AND CELLULAR PRESENILIN-2 (STM2) GENE-EXPRESSION IN THE HUMAN BRAIN

      NeuroReport
    59. PEZZOLI G; STRADA O; SILANI V; ZECCHINELLI A; PERBELLINI L; JAVOYAGID F; GHIDONI P; MOTTI EDF; MASINI T; SCARLATO G; AGID Y; HIRSCH EC
      CLINICAL AND PATHOLOGICAL FEATURES IN HYDROCARBON-INDUCED PARKINSONISM

      Annals of neurology
    60. MOUATTPRIGENT A; KARLSSON JO; AGID Y; HIRSCH EC
      INCREASED M-CALPAIN EXPRESSION IN THE MESENCEPHALON OF PATIENTS WITH PARKINSONS-DISEASE BUT NOT IN OTHER NEURODEGENERATIVE DISORDERS INVOLVING THE MESENCEPHALON - A ROLE IN NERVE-CELL DEATH

      Neuroscience
    61. HUNOT S; BOISSIERE F; FAUCHEUX B; BRUGG B; MOUATTPRIGENT A; AGID Y; HIRSCH EC
      NITRIC-OXIDE SYNTHASE AND NEURONAL VULNERABILITY IN PARKINSONS-DISEASE

      Neuroscience
    62. VILA M; LEVY R; HERRERO MT; FAUCHEUX B; OBESO JA; AGID Y; HIRSCH EC
      METABOLIC-ACTIVITY OF THE BASAL GANGLIA IN PARKINSONIAN SYNDROMES IN HUMAN AND NONHUMAN-PRIMATES - A CYTOCHROME-OXIDASE HISTOCHEMISTRY STUDY

      Neuroscience
    63. HUNOT S; BERNARD V; FAUCHEUX B; BOISSIERE F; LEGUERN E; BRANA C; GAUTRIS PP; GUERIN J; BLOCH B; AGID Y; HIRSCH EC
      GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR (GDNF) GENE-EXPRESSION INTHE HUMAN BRAIN - A POST-MORTEM IN-SITU HYBRIDIZATION STUDY WITH SPECIAL REFERENCE TO PARKINSONS-DISEASE

      Journal of neural transmission
    64. HERRERO MT; AUGOOD SJ; ASENSI H; HIRSCH EC; AGID Y; OBESO JA; EMSON PC
      EFFECTS OF L-DOPA-THERAPY ON DOPAMINE D-2 RECEPTOR MESSENGER-RNA EXPRESSION IN THE STRIATUM OF MPTP-INTOXICATED PARKINSONIAN MONKEYS

      Molecular brain research
    65. HERRERO MT; LEVY R; RUBERG M; LUQUIN MR; VILLARES J; GUILLEN J; FAUCHEUX B; JAVOYAGID F; GURIDI J; AGID Y; OBESO JA; HIRSCH EC
      CONSEQUENCE OF NIGROSTRIATAL DENERVATION AND L-DOPA THERAPY ON THE EXPRESSION OF GLUTAMIC-ACID DECARBOXYLASE MESSENGER-RNA IN THE PALLIDUM

      Neurology
    66. DAMIER P; KASTNER A; AGID Y; HIRSCH EC
      DOES MONOAMINE-OXIDASE TYPE-B PLAY A ROLE IN DOPAMINERGIC NERVE-CELL DEATH IN PARKINSONS-DISEASE

      Neurology
    67. VILA M; HERRERO MT; LEVY R; FAUCHEUX B; RUBERG M; GUILLEN J; LUQUIN MR; GURIDI J; JAVOYAGID F; AGID Y; OBESO JA; HIRSCH EC
      CONSEQUENCES OF NIGROSTRIATAL DENERVATION ON THE GAMMA-AMINOBUTYRIC ACIDIC NEURONS OF SUBSTANTIA-NIGRA PARS RETICULATA AND SUPERIOR COLLICULUS IN PARKINSONIAN SYNDROMES

      Neurology
    68. BOISSIERE F; FAUCHEUX B; HUNOT S; AGID Y; HIRSCH EC
      DECREASE OF TRKA MESSENGER-RNA CONTENT IN CHOLINERGIC NEURONS OF THE STRIATUM AND BASAL FOREBRAIN IN ALZHEIMERS-DISEASE

      Neurology
    69. DAMIER P; HIRSCH EC; AGID Y; GRAYBIEL AM
      PATTERNS OF CELL LOSS IN THE SUBSTANTIA-NIGRA IN PARKINSONS-DISEASE

      Neurology
    70. VILA M; LEVY R; HERRERO MT; FAUCHEUX B; AGID Y; HIRSCH EC
      METABOLIC-ACTIVITY OF THE BASAL GANGLIA IN PARKINSONIAN SYNDROMES IN HUMAN AND NONHUMAN-PRIMATES

      Neurology
    71. ANGLADE P; VYAS S; JAVOYAGID F; HERRERO MT; MICHEL PP; MARQUEZ J; MOUATTPRIGENT A; RUBERG M; HIRSCH EC; AGID Y
      APOPTOTIC DEGENERATION OF NIGRAL DOPAMINERGIC-NEURONS IN PARKINSONS-DISEASE

      Neurology
    72. HIRSCH EC; MOUATTPRIGENT A; KARLSSON JO; AGID Y
      CALPAIN, CALCIUM AND PARKINSONS-DISEASE

      Journal of neurochemistry
    73. BERNARD V; GARDIOL A; FAUCHEUX B; BLOCH B; AGID Y; HIRSCH EC
      EXPRESSION OF GLUTAMATE RECEPTORS IN THE HUMAN AND RAT BASAL GANGLIA - EFFECT OF THE DOPAMINERGIC DENERVATION ON AMPA RECEPTOR GENE-EXPRESSION IN THE STRIATOPALLIDAL COMPLEX IN PARKINSONS-DISEASE AND RAT WITH 6-OHDA LESION

      Journal of comparative neurology
    74. TROTTIER Y; DEVYS D; IMBERT G; SAUDOU F; AN I; LUTZ Y; WEBER C; AGID Y; HIRSCH EC; MANDEL JL
      CELLULAR-LOCALIZATION OF THE HUNTINGTONS-DISEASE PROTEIN AND DISCRIMINATION OF THE NORMAL AND MUTATED FORM

      Nature genetics
    75. ANGLADE P; TSUJI S; AGID Y; HIRSCH EC
      NEURONAL PLASTICITY AND PARKINSON DISEASE

      Molecular and chemical neuropathology
    76. LEVY R; HERRERO MT; RUBERG M; VILLARES J; FAUCHEUX B; GURIDI J; GUILLEN J; LUQUIN MR; JAVOYAGID F; OBESO JA; AGID Y; HIRSCH EC
      EFFECTS OF NIGROSTRIATAL DENERVATION AND L-DOPA THERAPY ON THE GABAERGIC NEURONS OF THE STRIATUM IN MPTP-TREATED MONKEYS AND PARKINSONS-DISEASE - AN IN-SITU HYBRIDIZATION STUDY OF GAD(67) MESSENGER-RNA

      European journal of neuroscience
    77. ANGLADE P; TSUJI S; JAVOYAGID F; AGID Y; HIRSCH EC
      PLASTICITY OF NERVE AFFERENTS TO NIGROSTRIATAL NEURONS IN PARKINSONS-DISEASE

      Annals of neurology
    78. HERRERO MT; AUGOOD SJ; HIRSCH EC; JAVOYAGID F; LUQUIN MR; AGID Y; OBESO JA; EMSON PC
      EFFECTS OF L-DOPA ON PREPROENKEPHALIN AND PREPROTACHYKININ GENE-EXPRESSION IN THE MPTP-TREATED MONKEY STRIATUM

      Neuroscience
    79. LEVY R; VILA M; HERRERO MT; FAUCHEUX B; AGID Y; HIRSCH EC
      STRIATAL EXPRESSION OF SUBSTANCE-P AND METHIONIN-ENKEPHALIN GENES IN PATIENTS WITH PARKINSONS-DISEASE

      Neuroscience letters
    80. KUBIS N; HIRSCH EC; FAUCHEUX B; RANSMAYR G; HAUW JJ; DUYCKAERTS C; HENIN D; MIKOL J; POLIVKA M; LECHARPENTIER Y; ROBAIN O; AGID Y
      VARIATION DURING AGING IN THE NUMBER OF BRAIN-STEM CATECHOLAMINERGIC NEURONS SELECTIVELY VULNERABLE IN PARKINSONS-DISEASE

      Neurology
    81. LEVY R; RUBERG M; HERRERO MT; VILLARES J; JAVOYAGID F; AGID Y; HIRSCH EC
      ALTERATIONS OF GABAERGIC NEURONS IN THE BASAL GANGLIA OF PATIENTS WITH SUPRANUCLEAR PALSY - AN IN-SITU HYBRIDIZATION STUDY OF GAD67 MESSENGER-RNA

      Neurology
    82. PEZZOLL G; STRADA O; SILANI V; ZECCHINELLI A; SCARLATO G; MILETICH RS; JAVOYAGIO F; AGID Y; HIRSCH EC
      CLINICAL AND PATHOLOGICAL FEATURES IN N-HEXANE-INDUCED PARKINSONISM

      Neurology
    83. DAMIER P; HIRSCH EC; KASTNER A; AGID Y
      IS OXIDATIVE-METABOLISM OF DOPAMINE IMPLICATED IN NERVE-CELL DEATH INPARKINSONS-DISEASE

      Neurology
    84. LEVY R; RUBERG M; HERRERO MT; VILLARES J; JAVOYAGID F; AGID Y; HIRSCH EC
      ALTERATIONS OF GABAERGIC NEURONS IN THE BASAL GANGLIA OF PATIENTS WITH PROGRESSIVE SUPRANUCLEAR PALSY - AN IN-SITU HYBRIDIZATION STUDY OF GAD(67) MESSENGER-RNA

      Neurology
    85. FAUCHEUX BA; NILLESSE N; DAMIER P; SPIK G; MOUATTPRIGENT A; PIERCE A; LEVEUGLE B; KUBIS N; HAUW JJ; AGID Y; HIRSCH EC
      EXPRESSION OF LACTOFERRIN RECEPTORS IS INCREASED IN THE MESENCEPHALONOF PATIENTS WITH PARKINSON DISEASE

      Proceedings of the National Academy of Sciences of the United Statesof America
    86. THIBAUT F; FAUCHEUX BA; MARQUEZ J; VILLARES J; MENARD JF; AGID Y; HIRSCH EC
      REGIONAL DISTRIBUTION OF MONOAMINE VESICULAR UPTAKE SITES IN THE MESENCEPHALON OF CONTROL SUBJECTS AND PATIENTS WITH PARKINSONS-DISEASE - APOSTMORTEM STUDY USING TRITIATED TETRABENAZINE

      Brain research
    87. FAUCHEUX BA; HERRERO MT; VILLARES J; LEVY R; JAVOYAGID F; OBESO JA; HAUW JJ; AGID Y; HIRSCH EC
      AUTORADIOGRAPHIC LOCALIZATION AND DENSITY OF [I-125] FERROTRANSFERRINBINDING-SITES IN THE BASAL GANGLIA OF CONTROL SUBJECTS, PATIENTS WITHPARKINSONS-DISEASE AND MPTP-LESIONED MONKEYS

      Brain research
    88. HIRSCH EC
      BIOCHEMISTRY OF PARKINSONS-DISEASE WITH SPECIAL REFERENCE TO THE DOPAMINERGIC SYSTEMS

      Molecular neurobiology
    89. BOISSIERE F; HUNOT S; FAUCHEUX B; MOUATTPRIGENT A; AGID Y; HIRSCH EC
      HIGH-AFFINITY NEUROTROPHIN RECEPTORS IN CHOLINERGIC NEURONS IN THE HUMAN BRAIN

      Comptes rendus de l'Academie des sciences. Serie 3, Sciences de la vie
    90. KASTNER A; HERRERO MT; HIRSCH EC; GUILLEN J; LUQUIN MR; JAVOYAGID F; OBESO JA; AGID Y
      DECREASED TYROSINE-HYDROXYLASE CONTENT IN THE DOPAMINERGIC-NEURONS OFMPTP-INTOXICATED MONKEYS - EFFECT OF LEVODOPA AND GM1 GANGLIOSIDE THERAPY

      Annals of neurology
    91. KASTNER A; ANGLADE P; BOUNAIX C; DAMIER P; JAVOYAGID F; BROMET N; AGID Y; HIRSCH EC
      IMMUNOHISTOCHEMICAL STUDY OF CATECHOL-O-METHYLTRANSFERASE IN THE HUMAN MESOSTRIATAL SYSTEM

      Neuroscience
    92. ZHANG P; ANGLADE P; HIRSCH EC; JAVOYAGID F; AGID Y
      DISTRIBUTION OF MANGANESE-DEPENDENT SUPEROXIDE-DISMUTASE IN THE HUMANBRAIN

      Neuroscience
    93. VILLARES J; STRADA O; FAUCHEUX B; JAVOYAGID F; AGID Y; HIRSCH EC
      LOSS OF STRIATAL HIGH-AFFINITY NGF BINDING-SITES IN PROGRESSIVE SUPRANUCLEAR PALSY BUT NOT IN PARKINSONS-DISEASE

      Neuroscience letters
    94. BOKA G; ANGLADE P; WALLACH D; JAVOYAGID F; AGID Y; HIRSCH EC
      IMMUNOCYTOCHEMICAL ANALYSIS OF TUMOR-NECROSIS-FACTOR AND ITS RECEPTORS IN PARKINSONS-DISEASE

      Neuroscience letters
    95. DAMIER P; AGID Y; HIRSCH EC
      IS INTRANEURONAL MONOAMINE OXIDASE-B A FACTOR OF VULNERABILITY FOR DOPAMINERGIC-NEURONS IN PARKINSONS-DISEASE

      Neurology
    96. MOUATTPRIGENT A; AGID Y; HIRSCH EC
      DOES THE CALCIUM-BINDING PROTEIN CALRETININ PROTECT DOPAMINERGIC-NEURONS AGAINST DEGENERATION IN PARKINSONS-DISEASE

      Brain research
    97. LEHERICY S; BRANDEL JP; HIRSCH EC; ANGLADE P; VILLARES J; SCHERMAN D; DUYCKAERTS C; JAVOYAGID F; AGID Y
      MONOAMINE VESICULAR UPTAKE SITES IN PATIENTS WITH PARKINSONS-DISEASE AND ALZHEIMERS-DISEASE, AS MEASURED BY TRITIATED DIHYDROTETRABENAZINE AUTORADIOGRAPHY

      Brain research
    98. HERRERO MT; HIRSCH EC; KASTNER A; LUQUIN MR; JAVOYAGID F; GONZALO LM; OBESO JA; AGID Y
      NEUROMELANIN ACCUMULATION WITH AGE IN CATECHOLAMINERGIC NEURONS FROM MACACA-FASCICULARIS BRAIN-STEM

      Developmental neuroscience
    99. ANGLADE P; HIRSCH EC; BRANDEL JP; JAVOYAGID F; DUYCKAERTS C; HAUW JJ; AGID Y
      ADRENAL TRANSPLANT, DOPAMINERGIC-NEURONS, AND PARKINSONS-DISEASE

      Annals of neurology
    100. HERRERO MT; PEREZOTANO I; OSET C; KASTNER A; HIRSCH EC; AGID Y; LUQUIN MR; OBESO JA; DELRIO J
      GM-1 GANGLIOSIDE PROMOTES THE RECOVERY OF SURVIVING MIDBRAIN DOPAMINERGIC-NEURONS IN MPTP-TREATED MONKEYS

      Neuroscience


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 15/08/20 alle ore 02:24:26